Venous Stents Market to Grow at a CAGR of 9.7% to reach US$ 1,727.4 Mn from 2017 to 2025

Venous Stents Market to 2025 - Global Analysis and Forecasts by Technology (Wallstent Technology and Iliac Vein Stent Technology); Application (Legs, Chest and Abdomen); Disease (Post Thrombotic Syndrome, Chronic Deep Vein Thrombosis, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Others); and Geography

Publication Month : Nov 2018

  • Report Code : TIPMD00002388
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 115
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The Venous stents in healthcare market was valued at US$ 829.0 million in 2017 and it is projected to reach US$ 1,727.4 million by 2025; it is expected to grow at a CAGR of 9.7% from 2018 to 2025.

The venous stents are mesh tubes made up metal that expands against the blocked veins or the narrowed veins. These stents play role of a scaffold that assist in keeping the walls of veins open. The venous stents are generally placed in the central veins which are found in legs, chest and abdomen. The venous stents are used to treat conditions such as chronic deep vein thrombosis (DVT), post thrombotic syndrome and more. The growth of the Venous stents in healthcare market is attributed to the rising venous diseases, technological advancements in stent technology and rising geriatric populations are key drivers for the growth of the market. However, the growth of the market is restrained by various factors such as stringent regulations for approval and high cost of surgical procedures.

The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Venous stents in Healthcare Market



Lucrative Regions for Venous stents in Healthcare Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Applications of Venous stents in Healthcare to Drive Venous stents in Healthcare Market Growth

Conditions that damage the veins are termed as venous diseases. Common venous disorders include: venous thrombosis, deep vein thrombosis, venous stasis, venous ulcers, arteriovenous fistula, post-thrombotic syndrome, thrombophlebitis and others. According to the Johns Hopkins University around 15% of the US population suffers from varicose veins. Also, according to the Centers for Disease Control and Prevention, every year approximately 900,000 (1 - 2 per 1,000) people are affected by deep vein thrombosis (DVT) in the United States. It also mentioned that 33% of people with DVT will have recurrence of DVT within 10 years. Furthermore, thrombophilia is the condition wherein predisposition leads to formation of clots. The predisposition to form clots can arise from genetic factors, genetic thrombophilia results when there is deficiency in inherited factor, such as antithrombin or protein C. The Centers for Disease Control and Prevention estimated that 5-8% people in the US have inherited thrombophilias. 

Owing to the rising cases of venous diseases in the regions and in various countries, the need and demand for the venous stents for the treatment of the venous disorders increases, thus enhancing the market growth in the future years.

Advancement in the field of stent technology has equally enhanced the market for venous stents. Many industry players have come up with innovative types of venous stents in last few years. The defects and technical shortcomings for performing venous stenting procedures have led to a revolution of the newer nitinol stents. For instance, in January 2018, Medtronic plc. broadcasted an initiation of its investigational device exemption (IDE) study for the Abre, its venous self-expanding stent system. The new abre stent is developed for permanent implant in the iliofemoral vein. Upon placement of the Abre stent, the stent offers optimized balance of strength and flexibility to exert an outward force and open the vein. Similarly, in November 2016, Cook Medical announced the initiation of VIVO clinical study that assesses the safety and effectiveness of the Zilver Vena venous stent that is used for the treatment of symptomatic iliofemoral venous outflow obstruction. Thus, many companies are growing their venous product portfolio to offer a comprehensive portfolio for the treatment of venous diseases. 

Advancement in venous stents has made the treatment of venous diseases easy and accurate. These technological advancements are likely to grow the market in near future.

Incidence rates for deep venous thrombosis (DVT) and pulmonary embolism (PE) increases with increasing age in both men and women. This is due to age related alterations in thrombotic factors and laxity in large venous valves. According to the NHS foundation, 90-95% of deep venous thrombosis or pulmonary embolism cases are in people aged over 40 years. Furthermore, chronic diseases like cancer, surgeries or immobilization, transvenous pacemaker, central venous catheters, infection, kidney disease, thrombophilia, and leg paresis from neurological disease are more prevalent in aged population and all these diseases are independent predictors of venous thromboembolism events. 

Globally the geriatric population is increasing, every country is experiencing the rise in older population. According to the United Nations data from World Population Prospects 2017, 962 million people are aged 60 or over in the world and is expected to reach 2.1 billion by 2050 and 3.1 billion by 2100. It also mentioned that Europe is having the largest share of old aged population about 25%. Thus, the growing geriatric population, increases the applications of venous stents and eventually favors market growth.

Technology-Based Insights

In terms of technology, the Venous stents in healthcare market is segmented into wallstent technology and iliac vein stent technology. In 2017, the iliac vein stent technology segment held a largest market share of 73.9% of the venous stents, by technology.

 

Venous stents in Healthcare Market, by Technology – 2017 and 2025



Venous stents in Healthcare Market, by Technology – 2017 and 2025
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Application-Based Insights

Based on application, the Venous stents in healthcare market is segmented into legs, chest, and abdomen. The leg segment is anticipated to grow at a CAGR of 9.6% during the forecast period. The growth of leg segment is primarily driven due to increasing number of the incidences for the deep vein thrombosis in the geriatric population.

Disease-Based Insights

In terms of disease, the Venous stents in healthcare market is segmented into post thrombotic syndrome, chronic deep vein thrombosis, may-thurner syndrome, hemodialysis/arteriovenous fistulae and others. In 2017, the chronic deep vein thrombosis segment held a largest market share of 30.4% of the venous stents, by disease.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Venous Stents Market: Strategic Insights

venous-stents-market
Market Size Value inUS$ 829.0 Million in 2017
Market Size Value byUS$ 1,727.4 Million by 2025
Growth rateCAGR of 9.7% from 2018-2025
Forecast Period2018-2025
Base Year2018
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The Venous stents in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Venous stents in Healthcare Market – by Technology

  • Wallstent Technology, 
  • Iliac Vein Stent Technology

Venous stents in Healthcare Market – by Application

  • Legs
  • Chest 
  • Abdomen

Venous stents in Healthcare Market – by Disease

  • Post Thrombotic Syndrome, 
  • Chronic Deep Vein Thrombosis, 
  • May-Thurner Syndrome, 
  • Hemodialysis/Arteriovenous Fistulae, and 
  • Others

Venous stents in Healthcare Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Boston Scientific Corporation
  • C. R Bard (acquired by BD)
  • Jotech GMBH (acquired by Cryolife, Inc.)
  • Cook
  • W.L Gore & Associates
  • Optimed Medizinische Instrumente GMBH
  • Medtronic
  • Medica Germany GMBH & Co. KG
  • Cordis
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Technology ; Application ; Disease ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List of Companies

  1. Boston Scientific Corporation
  2. C. R Bard (acquired by BD)
  3. Jotech GMBH (acquired by Cryolife, Inc.)
  4. Cook
  5. W.L Gore & Associates
  6. Optimed Medizinische Instrumente GMBH
  7. Medtronic
  8. Medica Germany GMBH & Co. KG
  9. Cordis (acquired by Cardinal Health)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Venous Stents Market